Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes

Irena Stefanova, Nathan Thompson, Lucy Oldfield, Martyn Stott, Robert Hanson, Daniel Palmer, Christopher Halloran, William Greenhalf, Robert Van Der Meer, Eithne Costello

Open source

DOI: 10.1001/jamanetworkopen.2025.38031
Published: 2025-10-17
Container: JAMA Network Open
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2025.38031,
  title = {Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes},
  author = {Irena Stefanova and Nathan Thompson and Lucy Oldfield and Martyn Stott and Robert Hanson and Daniel Palmer and Christopher Halloran and William Greenhalf and Robert Van Der Meer and Eithne Costello},
  year = {2025},
  journal = {JAMA Network Open},
  doi = {10.1001/jamanetworkopen.2025.38031},
  url = {https://doi.org/10.1001/jamanetworkopen.2025.38031}
}

RIS

TY  - JOUR
TI  - Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes
AU  - Irena Stefanova
AU  - Nathan Thompson
AU  - Lucy Oldfield
AU  - Martyn Stott
AU  - Robert Hanson
AU  - Daniel Palmer
AU  - Christopher Halloran
AU  - William Greenhalf
AU  - Robert Van Der Meer
AU  - Eithne Costello
PY  - 2025
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2025.38031
UR  - https://doi.org/10.1001/jamanetworkopen.2025.38031
ER  -

APA

Stefanova, I., Thompson, N., Oldfield, L., Stott, M., Hanson, R., Palmer, D., Halloran, C., Greenhalf, W., Meer, R. V. D., & Costello, E. (2025). Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.38031

Source records

crossref · retrieved 2026-09-25T08:47:01.131Z